Panacea Life Sciences Holdings, Inc. Gain (Loss) on Disposition of Assets for Financial Service Operations
Panacea Life Sciences Holdings, Inc. (PLSH) reported Gain (Loss) on Disposition of Assets for Financial Service Operations of -$538.58 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnSalesOfAssets · last filed 2024-04-01
- Panacea Life Sciences Holdings, Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2021-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2021-06-30 was -$297.35K, a 2685.66% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2020-12-31 was -$121.62K.
- Panacea Life Sciences Holdings, Inc. gain (loss) on disposition of assets for financial service operations for fiscal 2023 was -$538.58K.
- Panacea Life Sciences Holdings, Inc. gain (loss) on disposition of assets for financial service operations for fiscal 2021 was -$297.35K.
- Panacea Life Sciences Holdings, Inc. gain (loss) on disposition of assets for financial service operations for fiscal 2020 was -$140.71K.
| Period end | Gain (Loss) on Disposition of Assets for Financial Service Operations 3 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 6 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 9 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$538.58K 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | -$297.35K derived: sum of 3 quarters · filed 2023-03-30 | -$297.35K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$297.35K derived: sum of 2 quarters · filed 2022-11-14 | -$297.35K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$297.35K 10-Q · filed 2022-08-15 | -$297.35K 10-Q · filed 2022-08-15 | ||
| 2020-12-31 | -$121.62K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | -$73.00K derived: sum of 2 quarters · filed 2022-03-31 | -$61.50K derived: sum of 3 quarters · filed 2022-03-31 | -$140.71K 10-K · filed 2022-03-31 |
| 2020-09-30 | $48.62K 10-Q/A · filed 2021-12-20 | $60.12K derived: sum of 2 quarters · filed 2021-12-20 | -$19.09K 10-Q/A · filed 2021-12-20 | |
| 2020-06-30 | $11.50K 10-Q/A · filed 2021-12-20 | -$67.71K 10-Q/A · filed 2021-12-20 |